KCM
NPCE icon

Kornitzer Capital Management’s Neuropace NPCE Stock Holding History

Kornitzer Capital Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-199,919
Closed -$1.64M – 512
2022
Q1 		$1.64M Sell
199,919
-235,800
-54% -$2.03M 0.03% 369
2021
Q4 		$4.39M Sell
435,719
-17,293
-4% -$225K 0.07% 285
2021
Q3 		$7.18M Hold
453,012
– – 0.11% 251
2021
Q2 		$10.8M Buy
+453,012
New +$10.5M 0.16% 212

Other funds holding NPCE

KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM

Kornitzer Capital Management's NPCE Position: Q2 2022 in Review

Kornitzer Capital Management sold out of Neuropace (NPCE) in Q2 2022, closing a stake of 199,919 shares — an estimated $1.64M sold.

Kornitzer Capital Management first reported a position in NPCE in Q2 2021 and held it in 4 quarters. The position peaked at $10.8M in Q2 2021. 32 funds tracked by Wall St. Rank hold NPCE as of Q2 2022.

  • Kornitzer Capital Management reported no remaining Neuropace position as of Q2 2022 after selling out during the quarter.
  • Kornitzer Capital Management sold 199,919 Neuropace shares in Q2 2022, an estimated $1.64M.
  • Kornitzer Capital Management first reported a position in Neuropace in Q2 2021 and held it in 4 quarters.
  • Kornitzer Capital Management's Neuropace position peaked at $10.8M in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Neuropace as of Q2 2022.

Based on Kornitzer Capital Management's 13F filing for Q2 2022, filed 3 Aug 2022.